# Miltenyi Biotec

> Innovative biomedical research solutions

Business model and tags: B2B, Manufacturing, Hardware, Multi-product, Pharma & life sciences, Multi-site, International operations, Has production sites, Has in-house R&D, Has a works council

## About Miltenyi Biotec

Development of advanced science and technology integrating natural sciences, engineering, and informatics to support biomedical research and personalized medicine.

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 1,001–5,000 employees
- **Headquarters**: Bergisch Gladbach, North Rhine-Westphalia, Germany
- **Founded**: 1989
- **Revenue**: €30.3M (FY2025, filed accounts, INPI)
- **SIREN**: [419828900](https://annuaire-entreprises.data.gouv.fr/entreprise/419828900)
- **Website**: [miltenyibiotec.com](https://www.miltenyibiotec.com/)
- **LinkedIn**: [linkedin.com/company/miltenyi-biotec](https://www.linkedin.com/company/miltenyi-biotec)

## Jobs at Miltenyi Biotec

- [Manager, Quality Assurance (Audit & Supplier Quality) *PC 484](https://www.linkedin.com/jobs/view/4467103592/) · Gaithersburg, MD, United States · Oct 21, 2026

[See all 1 openings](https://www.tamtam.ai/c/miltenyi-biotec/jobs)

## Miltenyi Biotec in the news

- [ADSCC and Miltenyi sign collaboration agreement to advance local CAR-T cell therapy capabilities in the UAE](https://www.zawya.com/en/press-release/adscc-and-miltenyi-sign-collaboration-agreement-to-advance-local-car-t-cell-therapy-capabilities-in-the-uae-1837264) · zawya.com · Oct 22, 2026
  ADSCC and Miltenyi signed an MoU to develop and locally manufacture CAR-T cell therapies in the UAE, expanding patient access and strengthening the region's advanced cellular therapy capabilities.
- [Innovators in Healthcare: Markus Weiss, Miltenyi Biotec North America - Washington Business Journal](https://www.bizjournals.com/washington/c/innovators-in-healthcare-2026/48149/life-science-leader-of-the-year-markus-weiss.html) · bizjournals.com · Sep 26, 2026
  Markus Weiss of Miltenyi Biotec North America is recognized as an Innovator in Healthcare by the Washington Business Journal for his contributions.
- [Using TCR Repertoire Sequencing to Advance Immunology Research](https://www.the-scientist.com/using-tcr-repertoire-sequencing-to-advance-immunology-research-74803) · the-scientist.com · Aug 8, 2026
  This webinar, presented by Miltenyi Biotec, explores the applications and analysis of bulk T-cell receptor repertoire sequencing to advance immunology research and biomarker discovery.

[See all 20 articles](https://www.tamtam.ai/c/miltenyi-biotec/news)

## Miltenyi Biotec at a glance

Miltenyi Biotec is a B2B company in the Biotechnology Research industry, headquartered in Bergisch Gladbach, North Rhine-Westphalia, Germany.

Miltenyi Biotec was founded in 1989.

Miltenyi Biotec has 1,001–5,000 employees.

Miltenyi Biotec's revenue is €30.3M (FY2025, filed accounts, INPI).

Miltenyi Biotec's SIREN number is 419828900.

Miltenyi Biotec is hiring: 1 recent open role, including Manager, Quality Assurance (Audit & Supplier Quality) *PC 484.

## Frequently asked questions about Miltenyi Biotec

### What is Miltenyi Biotec's revenue?

Miltenyi Biotec's revenue is €30.3M (FY2025, filed accounts, INPI).

### How many employees does Miltenyi Biotec have?

Miltenyi Biotec has 1,001–5,000 employees.

### Where is Miltenyi Biotec headquartered?

Miltenyi Biotec is headquartered in Bergisch Gladbach, North Rhine-Westphalia, Germany.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/miltenyi-biotec
